Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Rho kinase inhibition as a therapeutic for progressive supranuclear palsy and corticobasal degeneration

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Gentry, E. G.
  • Henderson, B. W.
  • Arrant, A. E.
  • Gearing, M.
  • Feng, Yangbo
  • Riddle, N. C.
  • Herskowitz, J. H.

publication date

  • January 2016

journal

  • Journal of Neuroscience  Journal

subject areas

  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Animals, Genetically Modified
  • Basal Ganglia Diseases
  • Brain
  • Cell Line, Tumor
  • Drosophila
  • Enzyme Inhibitors
  • Female
  • Gene Expression Regulation, Enzymologic
  • Humans
  • Male
  • Middle Aged
  • Mutation
  • Nerve Degeneration
  • Neuroblastoma
  • Ribosomal Protein S6 Kinases, 70-kDa
  • Supranuclear Palsy, Progressive
  • TOR Serine-Threonine Kinases
  • rho-Associated Kinases
  • tau Proteins
scroll to property group menus

Research

keywords

  • Drosophila
  • ROCK
  • Rho kinase
  • autophagy
  • tau
  • tauopathy
scroll to property group menus

Identity

PubMed Central ID

  • PMC4728727

International Standard Serial Number (ISSN)

  • 0270-6474

Digital Object Identifier (DOI)

  • 10.1523/jneurosci.2336-15.2016

PubMed ID

  • 26818518
scroll to property group menus

Additional Document Info

start page

  • 1316

end page

  • 1323

volume

  • 36

issue

  • 4

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support